Express Scripts on Wednesday agreed to what the Federal Trade Commission called a "landmark settlement" promising major changes to its drug formulary practices, allowing the company to duck out of a case accusing all three of the country's largest pharmacy benefit managers of inflating insulin prices through rebate schemes.
Law360
Life Sciences
THURSDAY, FEBRUARY 5, 2026 Law360 iOS App Law360 Android App Follow Law360 on Facebook Follow Law360 on LinkedIn Follow Law360 on Twitter

TOP NEWS

9a2faf073e0b4641a4e5f6766f9b9606_Express_Scripts_Opioids_90031_4674x2982.jpg

Express Scripts Makes 'Fundamental Changes' In FTC Deal

By Bryan Koenig

Express Scripts on Wednesday agreed to what the Federal Trade Commission called a "landmark settlement" promising major changes to its drug formulary practices, allowing the company to duck out of a case accusing all three of the country's largest pharmacy benefit managers of inflating insulin prices through rebate schemes.

2 documents attached | Read full article » | Save to favorites »

'Careless Or Disingenuous': Judge Rips CareFirst Rethink Bid

By Hailey Konnath

A Virginia federal judge Wednesday refused to reconsider an order reversing course and throwing out key claims in CareFirst's suit against Johnson & Johnson over the immunosuppressive drug Stelara, calling CareFirst's arguments for doing so "either careless or disingenuous."

Order attached | Read full article » | Save to favorites »

Teva Wins 1st Paragard IUD Bellwether Trial

By Kelcey Caulder

Teva Pharmaceuticals won a complete defense verdict Tuesday in the first trial testing claims that the company failed to warn consumers that its Paragard IUD has a defect making it prone to breakage inside patients' uteri.

2 documents attached | Read full article » | Save to favorites »

Fed. Circ. Leans Toward Vacating $12.7M Copyright Award

By Madeline Lyskawa

The Federal Circuit appeared likely to vacate a $12.7 million copyright infringement award against the federal government on Wednesday, pressing attorneys for a software developer and the government to answer what instructions should be given to the claims court on remand.

Read full article » | Save to favorites »

Drugmaker Claims Stake In La. Mail-Order Abortion Meds Row

By Mark Payne

An abortion medication manufacturer asserted its right Wednesday to defend mifepristone, moving to intervene in a federal lawsuit over mail-order abortion medication brought by Louisiana alleging that regulators violated federal law by removing an in-person dispensing requirement for the drug.

Motion attached | Read full article » | Save to favorites »

Medtronic Owes $381M For Antitrust 'War Games,' Jury Told

By Craig Clough

An attorney for Applied Medical told a California federal jury Wednesday during closing arguments in an antitrust trial against Medtronic that internal documents from the medical device giant show it played illegal "war games" against his client and should pay up to $381 million. 

Read full article » | Save to favorites »

Law360 Seeks Members For Its 2026 Editorial Boards

Law360 is looking for avid readers of our publications to serve as members of our 2026 editorial advisory boards.

2 documents attached | Read full article » | Save to favorites »

LITIGATION

Whoop Nabs Block On Chinese Co.'s Health-Tracker Products

By Elliot Weld

A Massachusetts federal judge has blocked a Chinese company from selling in the U.S. its health-tracking products that were alleged by health band maker Whoop Inc. to be infringing its trade dress.

2 documents attached | Read full article » | Save to favorites »

Class Attys In Del. Northwest Biotherapeutics Praise Deal

By Jeff Montgomery

Delaware Chancery Court has lined up a March 16 settlement hearing for a four-year stockholder lawsuit alleging insiders of Northwest Biotherapeutics Inc. received $40 million in stock awards, with proposals including a call for the company to forfeit nearly 22.9 million stock options and it receiving $2.25 million.

Brief attached | Read full article » | Save to favorites »

Drugmakers Say Hagens Berman Responsible For Costs

By Emma Cueto

Drugmakers including GSK and Sanofi have told a Pennsylvania federal court that plaintiffs firm Hagens Berman Sobol Shapiro LLP should bear the costs for the special master tasked with sorting out long-running disputes in a since-dropped product liability suit.

Motion attached | Read full article » | Save to favorites »

Teva Fights Class Cert. Bid In Effexor Antitrust Case

By George Woolston

Teva Pharmaceuticals urged a New Jersey federal judge Wednesday to reject a class certification bid by a group of direct buyers of the antidepressant drug Effexor XR and its generic versions, arguing that the proposed class failed to carry its burden showing that joinder is impracticable.

Read full article » | Save to favorites »

Fertility Clinic Says Doctors Lured Staff To New Practice

By Julie Manganis

The owners of a Massachusetts fertility clinic say three doctors left to start their own practice and repeatedly violated a non-solicitation agreement to "raid" its staff, according to a complaint filed in state court.

Complaint attached | Read full article » | Save to favorites »

Walgreens Says Audio Recording Refutes Shareholders' Claim

By Celeste Bott

Walgreens told an Illinois federal judge Tuesday that newly discovered evidence warrants revisiting a decision allowing shareholders' claim over an executive's allegedly false statement to move forward, saying an audio recording shows "no basis to conclude the actual statement was false or misleading when made."

Memorandum attached | Read full article » | Save to favorites »

DEALS

Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger

By Al Barbarino

Regenerative medicine developer PrimeGen US said Wednesday it has agreed to go public through a merger with blank check company DT Cloud Star Acquisition Corp., in a deal that values the company at about $1.5 billion.

Read full article » | Save to favorites »

Ropes Leads Hair-Loss Firm Veradermics' Upsized $256M IPO

By Rae Ann Varona

Hair loss drug developer Veradermics Inc. began trading Wednesday after raising $256 million in an upsized initial public offering, with Ropes & Gray LLP representing the company and Cooley LLP representing the underwriters.

Read full article » | Save to favorites »

PEOPLE

Ex-Hogan Lovells Regulatory Atty Moves To Honigman In DC

By James Boyle

An attorney specializing in guiding life sciences companies through the U.S. Food and Drug Administration's regulatory process has moved her practice to Honigman LLP's Washington, D.C., office after more than 11 years with Hogan Lovells.

Read full article » | Save to favorites »

EXPERT ANALYSIS

New Biotech Nat'l Security Controls May Have Blunted Impact

While the newly enacted federal prohibition against contracting with certain biotechnology providers associated with countries of concern may have consequences on U.S. companies' ability to develop drugs, the restrictions may prove to be less problematic for the industry than the significant publicity around their passage would suggest, say attorneys at Wilson Sonsini.

Read full article » | Save to favorites »

From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination

With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.

Read full article » | Save to favorites »

Takeaways From The DOJ Fraud Section's 2025 Year In Review

Former acting Principal Deputy Chief Sean Tonolli of the U.S. Department of Justice's Fraud Section, now at Cahill Gordon, analyzes key findings from the section’s annual report — including the changes implemented to adapt to the new administration’s priorities — and lays out what to watch for this year.

Report attached | Read full article » | Save to favorites »

Series

Law School's Missed Lessons: Practicing Resilience

Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

Read full article » | Save to favorites »

LEGAL INDUSTRY

Paul Weiss' Karp Steps Back After Epstein Email Revelations

By Hailey Konnath and Aebra Coe

Longtime Paul Weiss Rifkind Wharton & Garrison LLP chair Brad S. Karp has resigned from his leadership role, the firm announced Wednesday, a move that comes after the U.S. Department of Justice released numerous emails between Karp and Jeffrey Epstein.

Read full article » | Save to favorites »

Baker McKenzie To Downsize Business Professional Jobs

By Tracey Read

Baker McKenzie, which has a legal services hub in Tampa, Florida, is in the process of downsizing business professionals' jobs, a firm spokesperson confirmed to Law360 Pulse on Wednesday.

Read full article » | Save to favorites »

Ex-DLA Piper Partner Aims To Toss Claim He Raped Associate

By Jack Karp

Allegations that an ex-DLA Piper partner raped a former Boston-based associate in Delaware in 2022 should be tossed since the Massachusetts state court the case was filed in has no jurisdiction over the Delaware claim, according to the accused former partner.

6 documents attached | Read full article » | Save to favorites »

Goldstein Accountant Admits Tax Return Errors

By Jared Foretek

A star government witness and the top outside accountant for SCOTUSblog founder Thomas Goldstein and his law firm admitted to making mistakes on Goldstein's tax returns and offering the grand jury erroneous testimony, under cross-examination in the U.S. Supreme Court lawyer's tax fraud trial Wednesday.

Read full article » | Save to favorites »

Analysis

Clemency Was 'Broken' Long Before Trump. Can It Be Fixed?

By Phillip Bantz

President Donald Trump has transformed what has historically been a bureaucratic process for seeking federal pardons and commutations into a more freewheeling affair with few clear rules — and no easy solutions for reform, experts say.

Read full article » | Save to favorites »

Wachtel Missry Settles Liability In $26M Atty Malpractice Case

By Emily Sawicki

A dispute over who is liable for a former Wachtel Missry LLP partner's alleged exploitation of an elderly client has been settled on the eve of trial, while the Brooklyn federal judge declined to consider recusing himself despite "inadvertently" meeting with the firm's founding partner before the matter was fully put to rest.

Order attached | Read full article » | Save to favorites »

Ex-Fox News Host Decries Judge Pick's Arbitration Stance

By Courtney Buble

Gretchen Carlson, a former Fox News anchor and a leading advocate for ending forced arbitration of sexual harassment and assault in the workplace, has come out against a federal judicial nominee for Louisiana for her past comments on the issue.

Read full article » | Save to favorites »

Trump Bid To Move NY Appeal Faces 'Fatal' Error, Judge Says

By Frank G. Runyeon

A Manhattan federal judge on Wednesday repeatedly aired doubts that President Donald Trump can upend the pending New York state appeal of his hush-money conviction by moving the case to federal court.

Read full article » | Save to favorites »

Promo that reads 2025 Practice Groups of the Year

COMPANIES IN TODAY'S NEWS

Aetna Inc.

Alliance Defending Freedom

Amazon.com Inc.

Apollo Global Management LLC

Applied Medical Resources Corp.

Atlantic Biologicals

Binance Holdings Ltd.

Boston IVF

CVS Health Corp.

Deloitte Touche Tohmatsu Ltd.

Democracy Forward Foundation

Eikon Therapeutics Inc.

Evernorth Health Services

Express Scripts Holding Co.

Guttmacher Institute

Johnson & Johnson

Kimberly-Clark Corp.

Liberty Mutual Insurance Group

LinkedIn Corp.

Longitude Capital

Medco Health Solutions Inc.

Medtronic PLC

Millicom International Cellular SA

Momenta Pharmaceuticals Inc.

Nasdaq Inc.

New York University

Northwest Biotherapeutics Inc.

OptumRx Inc.

Parabellum Capital LLC

Pfizer Inc.

Rite Aid Corp.

Sanofi

Teva Pharmaceutical Industries Ltd.

The Cigna Group

The Cooper Cos. Inc.

The New York Times Co.

UnitedHealth Group Inc.

Veradermics Inc.

VillageMD

Walgreens Boots Alliance Inc.

Wellington Management Co. LLP

Zinc Health Services LLC

LAW FIRMS IN TODAY'S NEWS

Ankner & Levy

Arnold & Porter

Ashby & Geddes

Baker McKenzie

Berger Montague

Butler Snow LLP

Cahill Gordon

Childers Schlueter

Ciardi Ciardi

Cleary Gottlieb

Cohn Lifland

Cooley LLP

Coppersmith Brockelman

Cravath Swaine

Croke Fairchild

DLA Piper

Dechert LLP

Fibich Leebron

Gibson Dunn

Glasser & Glasser

Goldman Ismail

Goldstein & Russell

Greenberg Traurig

Grogan Tuccillo

Hagens Berman

Hamilton Lincoln

Haynes Boone

Hogan Lovells

Honigman LLP

Johnson Siebeneicher

Keller Postman

Kirkland & Ellis

Knobbe Martens

Lehotsky Keller

Levi & Korsinsky

Libby Hoopes

Loeb & Loeb

Lowey Dannenberg

Lubin Austermuehle

McDermott Will & Schulte

McKool Smith

Mike Scott Law

Morgan Lewis

Motley Rice

Munger Tolles

Nelson Mullins

Paul Weiss

Pietragallo Gordon

Pollard PLLC

Pryor Cashman

Purcell & Lefkowitz

Quarles & Brady

Radice Law Firm

Reed Smith

Richards Layton

Ropes & Gray

Rosenberg Freedman

Rule Garza

Saxton & Stump

Schinko Law

Seyfarth Shaw

Shah Litigation

Shapiro Arato

Sichenzia Ross

Sidley Austin

Smith Katzenstein

Sullivan & Cromwell

Wachtel Missry

Welsh & Recker

Whiteford Taylor

Wilkinson Stekloff

Williams & Connolly

WilmerHale

Wilson Sonsini

GOVERNMENT AGENCIES IN TODAY'S NEWS

Alaska Department of Law

Commonwealth of Massachusetts

Defense Health Agency

Delaware Court of Chancery

Executive Office of the President

Federal Acquisition Regulatory Council

Federal Election Commission

Federal Trade Commission

Food and Drug Administration

Internal Revenue Service

Louisiana Attorney General's Office

Manhattan District Attorney's Office

National Institutes of Health

Patent Trial and Appeal Board

Superior Court of Massachusetts

U.S. Agency for International Development

U.S. Attorney's Office for the District of Maryland

U.S. Court of Appeals for the Federal Circuit

U.S. Department of Homeland Security

U.S. Department of Justice

U.S. Department of Veterans Affairs

U.S. District & Bankruptcy Courts of Southern District of Texas

U.S. District Court for the Central District of California

U.S. District Court for the District of Alaska

U.S. District Court for the District of Columbia

U.S. District Court for the District of Maryland

U.S. District Court for the District of Massachusetts

U.S. District Court for the District of New Jersey

U.S. District Court for the Eastern District of Louisiana

U.S. District Court for the Eastern District of New York

U.S. District Court for the Eastern District of Pennsylvania

U.S. District Court for the Eastern District of Virginia

U.S. District Court for the Northern District of Georgia

U.S. District Court for the Northern District of Illinois

U.S. District Court for the Northern District of Texas

U.S. District Court for the Southern District of Florida

U.S. District Court for the Southern District of New York

U.S. District Court for the Western District of Arkansas

U.S. District Court for the Western District of Missouri

U.S. District Court for the Western District of Texas

U.S. Patent and Trademark Office

U.S. Securities and Exchange Commission

U.S. Senate

U.S. Supreme Court

US Office of Management and Budget